New guidelines in the treatment of persistent central serous chorioretinopathy: PDT with half-dose verteporfin

Klinische Monatsblatter fur Augenheilkunde

Volumn 229, Issue 4, 2012, Pages 327-330

  Boni C ^a   Kloos, P ^a   Valmaggia, C ^a  

^a CANTONAL HOSPITAL ST GALLEN   (Switzerland)

Author keywords

central serous chorioretinopathy; half dose verteporfin; photodynamic therapy

Indexed keywords

VERTEPORFIN;

ADULT; AGED; ARTICLE; CENTRAL SEROUS RETINOPATHY; CLINICAL ARTICLE; CLINICAL EVALUATION; CONTROLLED STUDY; CORNEA THICKNESS; DRUG DOSE COMPARISON; DRUG EFFICACY; FEMALE; HUMAN; MALE; PHOTODYNAMIC THERAPY; PRACTICE GUIDELINE; RANK SUM TEST; RETINA FOVEA; RETROSPECTIVE STUDY; STATISTICAL SIGNIFICANCE; TREATMENT OUTCOME; VISUAL ACUITY;

CENTRAL SEROUS CHORIORETINOPATHY; CHRONIC DISEASE; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS; PORPHYRINS; RETROSPECTIVE STUDIES; SWITZERLAND; TREATMENT OUTCOME;

EID: 84859551469     PISSN: 00232165     EISSN: 14393999     Source Type: Journal    
DOI: 10.1055/s-0031-1299165     Document Type: Article

References (13)

1. Gass JD. Pathogenesis of disciform detachment of the neuroepithelium. Am J Ophthalmol: 1967; 63 03 1 139
2. Yannuzzi LA, Slakter JS, Gross NE et al. Indocyanine green angiography-guided photodynamic therapy for treatment of chronic central serous chorioretinopathy: a pilot study. Retina: 2003; 23 288 298 (Pubitemid 36792972)
3. Chan WM, Lam DS, Lai TY et al. Choroidal vascular remodelling in central serous chorioretinopathy after indocyanine green guided photodynamic therapy with verteporfin: a novel treatment at the primary disease level. Br J Ophthalmol: 2003; 87 1453 1458 (Pubitemid 38010546)
4. Cardillo Piccolino F, Eandi CM, Ventre L et al. Photodynamic therapy for chronic central serous chorioretinopathy. Retina: 2003; 23 752 763 (Pubitemid 38040573)
5. Lai TY, Chan WM, Lam DS. Transient reduction in retinal function revealed by multifocal electroretinogram after photodynamic therapy. Am J Ophthalmol: 2004; 137 826 833 (Pubitemid 38582034)
6. Lee PY, Kim KS, Lee WK. Severe choroidal ischemia following photodynamic therapy for pigment epithelial detachment and chronic central serous chorioretinopathy. Jpn J Ophthalmol: 2009; 53 52 56
7. Lai TY, Chan WM, Li H et al. Safety enhanced photodynamic therapy with half dose verteporfin for chronic central serous chorioretinopathy: a short term pilot study. Br J Ophthalmol: 2006; 90 869 874 (Pubitemid 43973998)
8. Chan WM, Lai TY, Lai RY et al. Safety enhanced photodynamic therapy for chronic central serous chorioretinopathy: one-year results of a prospective study. Retina: 2008; 28 85 93
9. Chan WM, Lai TY, Lai RY et al. Half-dose verteporfin photodynamic therapy for acute central serous chorioretinopathy: one-year results of a randomized controlled trial. Ophthalmology: 2008; 115 1756 1765
10. Zhao MW, Zhou P, Xiao HX et al. Photodynamic therapy for acute central serous chorioretinopathy: the safe effective lowest dose of verteporfin. Retina: 2009; 29 1155 1161
11. Reibaldi M, Cardascia N, Longo A et al. Standard-fluence versus low-fluence photodynamic therapy in chronic central serous chorioretinopathy: a nonrandomized clinical trial. Am J Ophthalmol: 2010; 149 307 315
12. Shin JY, Woo SJ, Yu HG et al. Comparison of efficacy and safety between half-fluence and full-fluence photodynamic therapy for chronic central serous chorioretinopathy. Retina: 2011; 31 119 126
13. Inoue R, Sawa M, Tsujikawa M et al. Association between the efficacy of photodynamic therapy and indocyanine green angiography findings for central serous chorioretinopathy. Am J Ophthalmol: 2010; 149 441 446